BACKGROUND: Intracranial germ cell tumors (GCTs) frequently take an insidious clinical course before diagnosis. To date, clinical latency has been discussed in the context of germinoma in the suprasellar area and basal ganglia. OBJECTIVE: In this study, we classified the clinical latency of intracranial GCTs into three categories and described their characteristics in order to understand the full spectrum of the phenomenon. METHODS: In a cohort of 181 patients with intracranial GCTs, 17 patients had a delayed diagnosis of more than 3 months (90 days) from the initial brain magnetic resonance imaging to the definitive GCT diagnosis. Clinical records and radiological data of the patients were reviewed. RESULTS: The patients with a delayed diagnosis were categorized into three groups according to their tumor location: suprasellar (nine patients), basal ganglia (six patients), and pineal (two patients). Initial symptomatology corresponded with the tumor location: central diabetes insipidus for the suprasellar group, hemiparesis for the basal ganglia group, and precocious puberty for the pineal group. The overall survival of patients with germinoma and delayed diagnosis was significantly shorter than that of patients who were diagnosed within 3 months (P = 0.002). CONCLUSIONS: Clinical latency and delayed diagnosis are not restricted to germinomas in the suprasellar area and basal ganglia; they are canonical features of intracranial GCTs including pineal non-germinomatous GCTs. Early detection and proactive diagnosis of these tumors are required because diagnosis delay may negatively influence patient survival.
BACKGROUND: Intracranial germ cell tumors (GCTs) frequently take an insidious clinical course before diagnosis. To date, clinical latency has been discussed in the context of germinoma in the suprasellar area and basal ganglia. OBJECTIVE: In this study, we classified the clinical latency of intracranial GCTs into three categories and described their characteristics in order to understand the full spectrum of the phenomenon. METHODS: In a cohort of 181 patients with intracranial GCTs, 17 patients had a delayed diagnosis of more than 3 months (90 days) from the initial brain magnetic resonance imaging to the definitive GCT diagnosis. Clinical records and radiological data of the patients were reviewed. RESULTS: The patients with a delayed diagnosis were categorized into three groups according to their tumor location: suprasellar (nine patients), basal ganglia (six patients), and pineal (two patients). Initial symptomatology corresponded with the tumor location: central diabetes insipidus for the suprasellar group, hemiparesis for the basal ganglia group, and precocious puberty for the pineal group. The overall survival of patients with germinoma and delayed diagnosis was significantly shorter than that of patients who were diagnosed within 3 months (P = 0.002). CONCLUSIONS: Clinical latency and delayed diagnosis are not restricted to germinomas in the suprasellar area and basal ganglia; they are canonical features of intracranial GCTs including pineal non-germinomatous GCTs. Early detection and proactive diagnosis of these tumors are required because diagnosis delay may negatively influence patient survival.
Authors: Lester Lee; Frank Saran; Darren Hargrave; István Bódi; Sanj Bassi; Tibor Hortobágyi Journal: Childs Nerv Syst Date: 2006-10-13 Impact factor: 1.475
Authors: S L Mootha; A J Barkovich; M M Grumbach; M S Edwards; S E Gitelman; S L Kaplan; F A Conte Journal: J Clin Endocrinol Metab Date: 1997-05 Impact factor: 5.958
Authors: Rodrigo V Ozelame; Manohar Shroff; Bradley Wood; Eric Bouffet; Ute Bartels; James M Drake; Cynthia Hawkins; Susan Blaser Journal: Pediatr Radiol Date: 2006-02-04
Authors: Ivan Chi Hin Siu; Noel Ching Yan Chan; Xian Lun Zhu; Ryan Pak To Yuen; Zhexi He; Danny Tat Ming Chan Journal: Neuroophthalmology Date: 2022-02-15
Authors: Sultan M Zain; Kanish Mirchia; Kristyn Galbraith; Michael A Galgano; Mijung Lee; Timothy E Richardson; Kavya Mirchia Journal: Radiol Case Rep Date: 2022-07-13
Authors: Jian Peng; Hao Zhou; Oliver Tang; Ken Chang; Panpan Wang; Xiaowei Zeng; Qin Shen; Jing Wu; Yanhe Xiao; Sohil H Patel; Chongyu Hu; Ke Jin; Bo Xiao; Jerrold Boxerman; Xiaoping Gao; Patrick Y Wen; Harrison X Bai; Raymond Y Huang; Li Yang Journal: Neuro Oncol Date: 2020-10-14 Impact factor: 12.300